Jinse Finance reported that Huajian Medical, a Hong Kong-listed company, has issued an announcement stating that the group has reached a strategic cooperation with Renhe International, a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd. Together, they will jointly establish a vertical RWA trading platform in the United States focused on the over-the-counter drug sector. (Zhitong Finance)